Related Experiment Video
Updated: Jul 31, 2026

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
Published on: March 14, 2011
Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T
T J Liegler1, M S Hayden, K H Lee
1Gladstone Institute of Virology and Immunology, San Francisco, California 94141-9100, USA.
Objective:
To evaluate CD4 T-cell cytopathicity of protease inhibitor (PI)-resistant isolates from patients with preserved CD4 cell counts after long-term virologic failure.
Methods:
PI-resistant primary isolates from 14 patients with stable or increasing CD4 T-cell counts despite long-term virologic failure during continuous combination therapy were examined. Replication and cytopathicity were assessed in activated peripheral blood mononuclear cell cultures in the presence and absence of PI using titered stocks of primary HIV-1 isolates and during initial viral isolation. Also studied were PI-sensitive isolates from four of these patients after therapy discontinuation and reversion to PI-sensitive virus and from seven antiretroviral drug-naive patients. Coreceptor use, syncytia-inducing (SI) phenotype and protease sequences were determined by standard methods.
Results:
All isolates obtained during continued therapy showed genetic markers of PI resistance and decreased phenotypic susceptibility. PI-resistant SI isolates were highly to moderately cytopathic whereas non-syncytia-inducing isolates were moderately to weakly cytopathic. PI-susceptible and PI-resistant isolates obtained after discontinuation of therapy were equally cytopathic at similar replication levels. The cytopathicity of PI-resistant isolates was not altered by PI and was similar to that of isolates from untreated subjects.
Conclusions:
Primary isolates from patients showing virologic rebound without net CD4 T-cell loss during continued therapy are as cytopathic as PI-sensitive isolates with equivalent input infectious titer. As with PI-sensitive isolates, cytopathicity of PI-resistant viruses was determined primarily by coreceptor preference. These results suggest that the sustained immunologic response observed after failure of PI-containing regimens is not due to the emergence of PI-resistant strains that are intrinsically less cytopathic for activated peripheral CD4 lymphocytes.
Insights
Protease inhibitor-resistant HIV isolates from patients with stable CD4 counts are as cytopathic as sensitive strains. Virus cytopathicity is mainly determined by coreceptor preference, not drug resistance.
Area of Science:
- Virology
- Immunology
- HIV Research
Background:
- Long-term virologic failure in HIV patients on protease inhibitor (PI) therapy can lead to PI-resistant viral strains.
- Some patients maintain stable or increasing CD4 T-cell counts despite virologic failure, suggesting compensatory mechanisms.
- The cytopathicity of PI-resistant HIV isolates and its impact on CD4 T-cell counts require further investigation.
Purpose of the Study:
- To evaluate the CD4 T-cell cytopathicity of protease inhibitor (PI)-resistant HIV isolates from patients with preserved CD4 cell counts after long-term virologic failure.
- To compare the cytopathicity of PI-resistant isolates with PI-sensitive isolates.
- To determine factors influencing the cytopathicity of PI-resistant HIV.
Main Methods:
- Primary HIV-1 isolates from 14 patients with virologic failure on PI therapy were analyzed.
- Replication and cytopathicity were assessed in peripheral blood mononuclear cell cultures.
- Coreceptor use, syncytia-inducing (SI) phenotype, and protease sequences were determined.
Main Results:
- PI-resistant isolates from patients on therapy showed decreased PI susceptibility.
- PI-resistant syncytia-inducing (SI) isolates were highly to moderately cytopathic; non-SI isolates were less cytopathic.
- The cytopathicity of PI-resistant isolates was similar to PI-sensitive isolates and not altered by PI presence.
Conclusions:
- Primary PI-resistant HIV isolates from patients with virologic rebound but stable CD4 counts are as cytopathic as PI-sensitive isolates.
- Coreceptor preference, not PI resistance, primarily determines HIV cytopathicity.
- Sustained immune responses after PI regimen failure are not due to less cytopathic PI-resistant strains.
Related Concept Videos
Retrovirus Life Cycles
Size and Structure of Viral Genomes
Inhibitors of Virion Maturation and Assembly

